WebCommon Technical Document Section. Recommendations per Guidance (GMP) Source Documents. Electronic Y/N. 3.2.S Drug Substance : 3.2.S.4 Control of Drug Substance : ... 3.2.P.5.6 Justification of Specifications. Justification for the proposed drug product specifications should be provided. Reference ICH guidances Q3B, Q6A, and Q6B. WebNov 18, 2014 · 3.2.P.5 Control of Drug Product 3.2.P.5.1 Specification(s) EN. ... CTD Module (Chemistry, Manufacturing, and Control) Eli Lilly and Company. Page 2. Shelf-Life Specifications. Test. Identification Tests. Analytical. Procedure. Acceptance Criteria. Potency Tests. Assay B01234 Not more than 95% and not less than 105%.
www.sanspo.com
WebM8 eCTD v3.2.2 Electronic Common Technical Document (eCTD) v3.2.2. The Implementation Guide and related documents for the ICH M8 electronic Common Technical Document (eCTD) v3.2.2 can be found on the ESTRI page. Date of Step 4: 1 July 2008. Status: Step 5. Implementation status: http://www.triphasepharmasolutions.com/Module%203%20Quality.htm fixtureworks work supports
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
WebJun 16, 2016 · Module 2 Common Technical Document Summaries; 2.1 Common Technical Document Table of Contents (Modules 2-5) 2.2 CTD Introduction; 2.3 Quality Overall Summary. Introduction; 2.3.S Drug Substance (Name, Manufacturer) 2.3.P Drug Product (Name, Dosage Form) 2.3.A Appendices; 2.3.R Regional Information; 2.4 … Web1/23/2024 7 13 Table 2: Module 3 (paper & eCTD v3.2.2) • R3 Revision (2004) o P.4 Control of Excipients documents, can be rolled-up into a single P.4 document, but still may be submitted at the lower P.4.x level if needed • R4 Revision (2016) o P.4.x documents can be rolled-up into a single P.4 document WebRead point 2.6.7.3 Toxicokinetics (instead of 2.7.7.3). Date of Step 4: 20 December 2002. ... The document proposes a review and revision in some parts of the Section 2.5 Clinical … fixtureworks.net